Photo

Photo detail

Urovant Chief Executive Keith Katkin

Stories this photo appears in:

Urovant Seeks $150M IPO

Irvine-based Urovant Sciences Inc. is seeking $150 million via the public markets to extend clinical trials of therapies to treat urologic conditions.

Tease photo